<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39190040</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8491</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>European archives of psychiatry and clinical neuroscience</Title><ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Subjective and objective measures of cognitive function are correlated in persons with Post-COVID-19 Condition: a secondary analysis of a Randomized Controlled Trial.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-024-01877-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It remains unclear whether subjective and objective measures of cognitive function in Post COVID-19 Condition (PCC) are correlated. The extent of correlation has mechanistic and clinical implications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial contains baseline data of subjective and objective measures of cognition in a rigorously characterized cohort living with PCC. Herein, we evaluated the association between subjective and objective condition function, as measured by the Perceived Deficits Questionnaire, 20-item (PDQ-20) and the Digit Symbol Substitution Test (DSST) and Trails Making Test (TMT)-A/B, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 152 participants comprised the baseline sample. Due to missing data, our statistical analyses included 150 for self-reported PDQ-20, 147 individuals for combined DSST-measured cognitive function (composite z-score of the Pen/Paper plus Online CogState Version, N<sub>combinedDSST</sub>), 71 for in-person DSST-measured cognitive function (Pen/Paper Version), 70 for TMT-A-measured cognitive function, and 70 for TMT-B-measured cognitive function. After adjusting for age, sex, and education, PDQ-20 was significantly correlated with pen-and-paper DSST (&#x3b2; = -0.003, p&#x2009;=&#x2009;0.002) and TMT-B (&#x3b2;&#x2009;=&#x2009;0.003, p&#x2009;=&#x2009;0.008) scores, but not with TMT-A scores (&#x3b2; = -0.001, p&#x2009;=&#x2009;0.751).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Overall, a statistically significant correlation was observed between subjective and objective cognitive functions. Clinicians providing care for individuals with PCC who have subjective cognitive function complaints may consider taking a measurement-based approach to cognition at the point of care that focuses exclusively on patient-reported measures.</AbstractText><CopyrightInformation>&#xa9; 2024. Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Angela T H</ForeName><Initials>ATH</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakhani</LastName><ForeName>Moiz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Gia Han</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Gurkaran</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teopiz</LastName><ForeName>Kayla M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceban</LastName><ForeName>Felicia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nijjar</LastName><ForeName>Charnjit S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meshkat</LastName><ForeName>Shakila</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badulescu</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore, 119077, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Taeho Greg</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Vincenzo</LastName><ForeName>Joshua D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Hartej</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Roger S</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0003-4013-1112</Identifier><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada. roger.mcintyre@bcdf.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. roger.mcintyre@bcdf.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada. roger.mcintyre@bcdf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>H. Lundbeck A/S</GrantID><Agency>H. Lundbeck A/S</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA><NlmUniqueID>9103030</NlmUniqueID><ISSNLinking>0940-1334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2024 Mar 21:2024.03.20.24304410. doi: 10.1101/2024.03.20.24304410</RefSource><PMID Version="1">38562707</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Eur Arch Psychiatry Clin Neurosci. 2024 Sep 22. doi: 10.1007/s00406-024-01910-z</RefSource><PMID Version="1">39307886</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognitive function</Keyword><Keyword MajorTopicYN="N">Depressive symptoms</Keyword><Keyword MajorTopicYN="N">Digit symbol substitution test (DSST)</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Objective Cognition</Keyword><Keyword MajorTopicYN="N">Perceived deficits Questionnaire, 20-item (PDQ-20)</Keyword><Keyword MajorTopicYN="N">Post-COVID Condition (PCC)</Keyword><Keyword MajorTopicYN="N">Quick inventory of depressive symptomatology (16-Item) (Self-Report) (QIDS-SR16)</Keyword><Keyword MajorTopicYN="N">Subjective cognition</Keyword><Keyword MajorTopicYN="N">Trails making test (TMT)-A/B</Keyword><Keyword MajorTopicYN="N">World Health Organization (WHO)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39190040</ArticleId><ArticleId IdType="doi">10.1007/s00406-024-01877-x</ArticleId><ArticleId IdType="pii">10.1007/s00406-024-01877-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ceban F, Ling S, Lui LMW et al (2022) Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 101:93&#x2013;135</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Organization W (2023) accessed Aug 10,. &#x41a;&#x43b;&#x438;&#x43d;&#x438;&#x447;&#x435;&#x441;&#x43a;&#x43e;&#x435; &#x43e;&#x43f;&#x440;&#x435;&#x434;&#x435;&#x43b;&#x435;&#x43d;&#x438;&#x435; &#x441;&#x43b;&#x443;&#x447;&#x430;&#x44f; &#x441;&#x43e;&#x441;&#x442;&#x43e;&#x44f;&#x43d;&#x438;&#x44f; &#x43f;&#x43e;&#x441;&#x43b;&#x435; COVID-19 &#x43c;&#x435;&#x442;&#x43e;&#x434;&#x43e;&#x43c; &#x434;&#x435;&#x43b;&#x44c;&#x444;&#x438;&#x439;&#x441;&#x43a;&#x43e;&#x433;&#x43e; &#x43a;&#x43e;&#x43d;&#x441;&#x435;&#x43d;&#x441;&#x443;&#x441;&#x430;. https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-rus.pdf</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22:e102&#x2013;e107</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Weatherley-Jones E, Nicholl JP, Thomas KJ et al (2004) A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. J Psychosom Res 56:189&#x2013;197</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(03)00377-5</ArticleId><ArticleId IdType="pubmed">15016577</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F (2022) Cognitive deficits in long Covid-19. N Engl J Med 387:1813&#x2013;1815</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21:133&#x2013;146</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Neumann C, Bahmer T et al (2022) Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. EClinicalMedicine 53:101651</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId><ArticleId IdType="pmc">9482331</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C et al (2022) Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328:1604&#x2013;1615</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">9552043</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihlaja RE, Kauhanen L-LS, Ollila HS et al (2023) Associations of subjective and objective cognitive functioning after COVID-19: a six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav Immun Health 27:100587</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100587</ArticleId><ArticleId IdType="pubmed">36624888</ArticleId><ArticleId IdType="pmc">9812472</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchberger I, Peilst&#xf6;cker D, Warm TD et al (2023) Subjective and objective cognitive impairments in Non-hospitalized persons 9 months after SARS-CoV-2 infection. Viruses 15. https://doi.org/10.3390/v15010256</Citation></Reference><Reference><Citation>Guo P, Benito Ballesteros A, Yeung SP et al (2022) COVCOG 2: cognitive and memory deficits in long COVID: a second publication from the COVID and Cognition Study. Front Aging Neurosci 14:804937</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId><ArticleId IdType="pmc">8967943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatys-Bogacka Z, Mazurkiewicz I, Slowik J et al (2022) Brain Fog and Quality of Life at Work in Non-hospitalized patients after COVID-19. Int J Environ Res Public Health 19. https://doi.org/10.3390/ijerph191912816</Citation></Reference><Reference><Citation>Chasco EE, Dukes K, Jones D, Comellas AP, Hoffman RM, Garg A (2022) Brain fog and fatigue following COVID-19 infection: an exploratory study of patient experiences of long COVID. Int J Environ Res Public Health 19. https://doi.org/10.3390/ijerph192315499</Citation></Reference><Reference><Citation>Schild A-K, Scharfenberg D, Kirchner L et al (2023) Subjective and objective cognitive deficits in patients with Post-COVID syndrome. Z f&#xfc;r Neuropsychologie 34:99&#x2013;110</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/1016-264X/a000374</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Johnsen S, Sattler SM et al (2021) Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol 46:39&#x2013;48</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId><ArticleId IdType="pmc">8006192</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre RS, Cha DS, Soczynska JK et al (2013) Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety 30:515&#x2013;527</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.22063</ArticleId><ArticleId IdType="pubmed">23468126</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansur RB, Lee Y, Zhou AJ et al (2018) Determinants of cognitive function in individuals with type 2 diabetes mellitus: a meta-analysis. Ann Clin Psychiatry 30:38&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pubmed">29373617</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisurapanont M, Suttajit S, Eurviriyanukul K, Varnado P (2017) Discrepancy between objective and subjective cognition in adults with major depressive disorder. Sci Rep 7:3901</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04353-w</ArticleId><ArticleId IdType="pubmed">28634383</ArticleId><ArticleId IdType="pmc">5478612</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Trojano L, De Micco R et al (2021) Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson&#x2019;s disease. J Neurol 268:3444&#x2013;3455</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10519-4</ArticleId><ArticleId IdType="pubmed">33723623</ArticleId><ArticleId IdType="pmc">8357714</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra-Blasco M, Torres IJ, Vicent-Gil M et al (2019) Discrepancy between objective and subjective cognition in major depressive disorder. Eur Neuropsychopharmacol 29:46&#x2013;56</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2018.11.1104</ArticleId><ArticleId IdType="pubmed">30503099</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan M, Wang X, Gong M, Wang Q, Li Y, Jia J (2023) Post-COVID cognitive dysfunction: current status and research recommendations for high risk population. Lancet Reg Health West Pac 38:100836</Citation><ArticleIdList><ArticleId IdType="pubmed">37457901</ArticleId><ArticleId IdType="pmc">10344681</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen MC, Loft H, McIntyre RS (2018) Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: a novel dual outcome measure in depressive disorders. J Affect Disord 227:787&#x2013;794</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2017.11.081</ArticleId><ArticleId IdType="pubmed">29689693</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre RS, Phan L, Kwan ATH et al (2023) Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain. published online Nov 4 https://doi.org/10.1093/brain/awad377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad377</ArticleId></ArticleIdList></Reference><Reference><Citation>ICH Official web site: ICH (2024) https://www.ich.org/page/efficacy-guidelines</Citation></Reference><Reference><Citation>WMA declaration of Helsinki (2024) &#x2013; ethical principles for medical research involving human subjects. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/</Citation></Reference><Reference><Citation>Perceived Deficits Questionnaire (PDQ) (2024) National Multiple Sclerosis Society. https://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-MS-Researchers/Research-Tools/Clinical-Study-Measures/Perceived-Deficits-Questionnaire-(PDQ )</Citation></Reference><Reference><Citation>Sobrino-Rela&#xf1;o S, Balboa-Bandeira Y, Pe&#xf1;a J, Ibarretxe-Bilbao N, Zubiaurre-Elorza L, Ojeda N (2023) Neuropsychological deficits in patients with persistent COVID-19 symptoms: a systematic review and meta-analysis. Sci Rep 13:10309</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-37420-6</ArticleId><ArticleId IdType="pubmed">37365191</ArticleId><ArticleId IdType="pmc">10293265</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Palmer K, Calandri I et al (2022) Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement 18:1047&#x2013;1066</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandolesi L, Polverino A, Montuori S et al (2018) Effects of Physical Exercise on Cognitive Functioning and Wellbeing: Biological and Psychological benefits. Front Psychol 9:509</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2018.00509</ArticleId><ArticleId IdType="pubmed">29755380</ArticleId><ArticleId IdType="pmc">5934999</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri S, Shaheen M, Grover B (2023) Nutrition and cognitive health: a life course approach. Front Public Health 11:1023907</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1023907</ArticleId><ArticleId IdType="pubmed">37050953</ArticleId><ArticleId IdType="pmc">10083484</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart SA (2005) The effects of benzodiazepines on cognition. J Clin Psychiatry 66(Suppl 2):9&#x2013;13</Citation><ArticleIdList><ArticleId IdType="pubmed">15762814</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahachi T, Ishii R, Iwase M et al (2008) Frontal activity during the digit symbol substitution test determined by multichannel near-infrared spectroscopy. Neuropsychobiology 57:151&#x2013;158</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000147467</ArticleId><ArticleId IdType="pubmed">18654084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>